GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Staidson (Beijing) Biopharmaceuticals Co Ltd (SZSE:300204) » Definitions » Price-to-Tangible-Book

Staidson (Beijing) Biopharmaceuticals Co (SZSE:300204) Price-to-Tangible-Book : 2.94 (As of Jun. 24, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Staidson (Beijing) Biopharmaceuticals Co Price-to-Tangible-Book?

As of today (2024-06-24), Staidson (Beijing) Biopharmaceuticals Co's share price is ¥5.55. Staidson (Beijing) Biopharmaceuticals Co's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was ¥1.89. Hence, Staidson (Beijing) Biopharmaceuticals Co's Price to Tangible Book Ratio of today is 2.94.

The historical rank and industry rank for Staidson (Beijing) Biopharmaceuticals Co's Price-to-Tangible-Book or its related term are showing as below:

SZSE:300204' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.21   Med: 4.16   Max: 7.75
Current: 2.94

During the past 13 years, Staidson (Beijing) Biopharmaceuticals Co's highest Price to Tangible Book Ratio was 7.75. The lowest was 2.21. And the median was 4.16.

SZSE:300204's Price-to-Tangible-Book is ranked worse than
55.43% of 1207 companies
in the Biotechnology industry
Industry Median: 2.63 vs SZSE:300204: 2.94

A closely related ratio is called PB Ratio. As of today, Staidson (Beijing) Biopharmaceuticals Co's share price is ¥5.55. Staidson (Beijing) Biopharmaceuticals Co's Book Value per Sharefor the quarter that ended in Mar. 2024 was ¥2.15. Hence, Staidson (Beijing) Biopharmaceuticals Co's P/B Ratio of today is 2.58.


Staidson (Beijing) Biopharmaceuticals Co Price-to-Tangible-Book Historical Data

The historical data trend for Staidson (Beijing) Biopharmaceuticals Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Staidson (Beijing) Biopharmaceuticals Co Price-to-Tangible-Book Chart

Staidson (Beijing) Biopharmaceuticals Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.39 2.94 5.80 5.27 5.37

Staidson (Beijing) Biopharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.30 4.19 4.49 5.37 3.58

Competitive Comparison of Staidson (Beijing) Biopharmaceuticals Co's Price-to-Tangible-Book

For the Biotechnology subindustry, Staidson (Beijing) Biopharmaceuticals Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Staidson (Beijing) Biopharmaceuticals Co's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Staidson (Beijing) Biopharmaceuticals Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Staidson (Beijing) Biopharmaceuticals Co's Price-to-Tangible-Book falls into.



Staidson (Beijing) Biopharmaceuticals Co Price-to-Tangible-Book Calculation

Staidson (Beijing) Biopharmaceuticals Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=5.55/1.889
=2.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Staidson (Beijing) Biopharmaceuticals Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Staidson (Beijing) Biopharmaceuticals Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Staidson (Beijing) Biopharmaceuticals Co (SZSE:300204) Business Description

Traded in Other Exchanges
N/A
Address
Rongjing Dong Street, No 5 Beijing Economic and Technological Development Zone, Beijing, CHN, 100176
Staidson (Beijing) Biopharmaceuticals Co Ltd is a pharmaceutical company mainly engaged in the research, development, production, and sale of biological products in China. Its products include mouse nerve growth factor injection, intravenous compound polyethylene glycol electrolyte powder solution, gliclazide, nabumetone, and aspirin.
Executives
Zhang Hong Shan Supervisors
Zheng Hong Supervisors
Cheng Jiang Hong Executives
Feng Yu Jing Executives
Ma Li Na Secretary, Director
Zhou Zhi Wen Director
Wang Huan Securities Affairs Representative
Zhang Rong Qin Executives
Xu Jiang Ping Executives
Cao Hai Yan Supervisors
Sun Yan Fang Executives
Jiang Li Xin Director
Gu Jian Ping Director
Xu Xiang Qing Supervisors
Gu Zhen Qi Director

Staidson (Beijing) Biopharmaceuticals Co (SZSE:300204) Headlines

No Headlines